157 related articles for article (PubMed ID: 33827092)
1. Comorbidity and Therapeutic Approaches in Patients with Necrobiosis Lipoidica.
Erfurt-Berge C; Heusinger V; Reinboldt-Jockenhöfer F; Dissemond J; Renner R
Dermatology; 2022; 238(1):148-155. PubMed ID: 33827092
[TBL] [Abstract][Full Text] [Related]
2. Update on clinical and laboratory features in necrobiosis lipoidica: a retrospective multicentre study of 52 patients.
Erfurt-Berge C; Seitz AT; Rehse C; Wollina U; Schwede K; Renner R
Eur J Dermatol; 2012; 22(6):770-5. PubMed ID: 23114030
[TBL] [Abstract][Full Text] [Related]
3. Updated results of 100 patients on clinical features and therapeutic options in necrobiosis lipoidica in a retrospective multicentre study.
Erfurt-Berge C; Dissemond J; Schwede K; Seitz AT; Al Ghazal P; Wollina U; Renner R
Eur J Dermatol; 2015; 25(6):595-601. PubMed ID: 26575980
[TBL] [Abstract][Full Text] [Related]
4. Fumaric acid esters in necrobiosis lipoidica: results of a prospective noncontrolled study.
Kreuter A; Knierim C; Stücker M; Pawlak F; Rotterdam S; Altmeyer P; Gambichler T
Br J Dermatol; 2005 Oct; 153(4):802-7. PubMed ID: 16181464
[TBL] [Abstract][Full Text] [Related]
5. Clinical Features and Comorbidities of Patients With Necrobiosis Lipoidica With or Without Diabetes.
Hashemi DA; Brown-Joel ZO; Tkachenko E; Nelson CA; Noe MH; Imadojemu S; Vleugels RA; Mostaghimi A; Wanat KA; Rosenbach M
JAMA Dermatol; 2019 Apr; 155(4):455-459. PubMed ID: 30785603
[TBL] [Abstract][Full Text] [Related]
6. Necrobiosis Lipoidica.
Sibbald C; Reid S; Alavi A
Dermatol Clin; 2015 Jul; 33(3):343-60. PubMed ID: 26143418
[TBL] [Abstract][Full Text] [Related]
7. Treatment-resistant ulcerative necrobiosis lipoidica in a diabetic patient responsive to ustekinumab.
Pourang A; Sivamani RK
Dermatol Online J; 2019 Aug; 25(8):. PubMed ID: 31553866
[TBL] [Abstract][Full Text] [Related]
8. Necrobiosis lipoidica with rapid response to doxycycline.
Burns E; Ukoha U; Chan A
Pediatr Dermatol; 2020 Sep; 37(5):981-982. PubMed ID: 32681529
[TBL] [Abstract][Full Text] [Related]
9. A Breakthrough in the Treatment of Necrobiosis Lipoidica? Update on Treatment, Etiopathogenesis, Diagnosis, and Clinical Presentation.
Naumowicz M; Modzelewski S; Macko A; Łuniewski B; Baran A; Flisiak I
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542454
[TBL] [Abstract][Full Text] [Related]
10. Fumaric acid esters in severe ulcerative necrobiosis lipoidica: a case report and evaluation of current therapies.
Eberle FC; Ghoreschi K; Hertl M
Acta Derm Venereol; 2010; 90(1):104-6. PubMed ID: 20107745
[No Abstract] [Full Text] [Related]
11. Necrobiosis lipoidica: a descriptive study of 35 cases.
Marcoval J; Gómez-Armayones S; Valentí-Medina F; Bonfill-Ortí M; Martínez-Molina L
Actas Dermosifiliogr; 2015 Jun; 106(5):402-7. PubMed ID: 25728565
[TBL] [Abstract][Full Text] [Related]
12. Treatment options for necrobiosis lipoidica: a systematic review.
Nihal A; Caplan AS; Rosenbach M; Damsky W; Mangold AR; Shields BE
Int J Dermatol; 2023 Dec; 62(12):1529-1537. PubMed ID: 37772666
[TBL] [Abstract][Full Text] [Related]
13. Cofactors and comorbidities of necrobiosis lipoidica: analysis of the German DRG data from 2012.
Jockenhöfer F; Kröger K; Klode J; Renner R; Erfurt-Berge C; Dissemond J
J Dtsch Dermatol Ges; 2016 Mar; 14(3):277-84. PubMed ID: 26972191
[TBL] [Abstract][Full Text] [Related]
14. Clearance of necrobiosis lipoidica with fumaric acid esters.
Gambichler T; Kreuter A; Freitag M; Pawlak FM; Brockmeyer NH; Altmeyer P
Dermatology; 2003; 207(4):422-4. PubMed ID: 14657645
[No Abstract] [Full Text] [Related]
15. Therapy of noninfectious granulomatous skin diseases with fumaric acid esters.
Breuer K; Gutzmer R; Völker B; Kapp A; Werfel T
Br J Dermatol; 2005 Jun; 152(6):1290-5. PubMed ID: 15948995
[TBL] [Abstract][Full Text] [Related]
16. Atypical Ulcerative Necrobiosis Lipoidica Diabeticorum: A Case Study.
Blevins M
Int J Low Extrem Wounds; 2023 Mar; 22(1):185-189. PubMed ID: 33745343
[TBL] [Abstract][Full Text] [Related]
17. Pentoxifylline: An effective therapy for necrobiosis lipoidica.
Wee E; Kelly R
Australas J Dermatol; 2017 Feb; 58(1):65-68. PubMed ID: 26559761
[TBL] [Abstract][Full Text] [Related]
18. Treatment of ulcerative necrobiosis lipoidica with topical calcineurin inhibitor: case report and literature review.
Binamer Y; Sowerby L; El-Helou T
J Cutan Med Surg; 2012; 16(6):458-61. PubMed ID: 23149208
[TBL] [Abstract][Full Text] [Related]
19. Treatment of necrobiosis lipoidica with topical psoralen plus ultraviolet A.
De Rie MA; Sommer A; Hoekzema R; Neumann HA
Br J Dermatol; 2002 Oct; 147(4):743-7. PubMed ID: 12366422
[TBL] [Abstract][Full Text] [Related]
20. Ulcerated necrobiosis lipoidica as a rare cause for chronic leg ulcers: case report series of ten patients.
Franklin C; Stoffels-Weindorf M; Hillen U; Dissemond J
Int Wound J; 2015 Oct; 12(5):548-54. PubMed ID: 24119190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
